Enrollment in a clinical trial may give your journey more meaning. And while the path is personal, we know the process of choosing to participate in a clinical trial may be challenging. Learn more about trial opportunities and information to discuss with your care team – so you can explore what may be possible in clinical trials, together.
CURRENT AREAS OF RESEARCH
Insmed is committed to helping people with serious diseases. We’re currently conducting research in the following areas:
Nontuberculous mycobacterial (NTM) lung disease is a rare and serious disorder most commonly caused by Mycobacterium avium complex (MAC). Symptoms may worsen over time and include chronic cough, dyspnea, fatigue, fever, weight loss, and chest pain. In some cases, NTM lung disease can cause severe lung damage.
Chronic Rhinosinusitis (CRS) is inflammation of both the nose and sinuses, including nasal blockage or discharge.
HS is a long-term inflammatory condition that affects areas of the skin with hair follicles and sweat glands, such as the armpits, groin, under the breasts, and buttocks. It causes painful lumps or boils that can rupture and leak pus, often leading to scarring. In more severe cases, tunnels (sinus tracts) can form under the skin, connecting different lesions.
Pulmonary hypertension (PH) is a rare, progressive disease in which the arteries of the lungs become narrowed and stiff. This causes high blood pressure (hypertension) in these arteries.
DMD is a genetic condition that causes progressive muscle weakness. It primarily affects young males and is caused by a mutation in the gene responsible for producing dystrophin, a protein that helps keep muscles strong.
Actor portrayal
Latest Clinical Trials
Learn more about our current clinical trials. Be sure to talk to your doctor and care team to see if one is right for you.
Nontuberculous Mycobacterial (NTM) Lung Disease
A Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex
A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)
As research opens new doors to finding ways to diagnose, prevent, treat, or cure disease and disability, clinical trial participation is essential to help us find the answers.
What’s in it for you?
Getting involved in clinical trials helps to advance our understanding of science and diseases. In addition, some patients who join may gain access to:
Better condition understanding Access to diagnostic tests and education from research team
Enhanced care and monitoring Frequent and comprehensive checkups with detailed assessments
Thorough screening process In-depth evaluations that may affect your condition management
Psychological or emotional value A proactive approach to address overall health
Personalized support Gained resources including clinicians and care team
Reimbursement for costs Participation often includes covering study-related expenses
All clinical trials are different and experiences may vary.
Actor portrayal
It’s also important to keep these factors in mind when deciding whether to apply to a clinical trial:
Convenience of the trial location Participation could require significant travel to the nearest trial location
Medication may come with side effects Early testing results may also uncover potential safety concerns
Effectiveness of the drug Positive treatment results are not guaranteed for trial participants
Experimental treatment may not be given to participants Those in the “control” group may be given a placebo instead of investigational drug
Significant time commitment For trial participants as well as caregivers and loved ones that are involved
Impact on daily life Participation may disrupt daily routines and activities
Actor portrayal
Ask your healthcare provider about clinical trials and learn more about patient advocacy groups that may be suited for you.
Testimonial from a clinical trial participant
“I was nervous when I decided to check out clinical trials for my condition, but I knew I needed something different.”